- Home
- EFOI vs LPCN Comparison
EFOI vs LPCN Comparison
Compare EFOI & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFOI
- LPCN
- Stock Information
- Founded
- EFOI 1985
- LPCN 1997
- Country
- EFOI United States
- LPCN United States
- Employees
- EFOI N/A
- LPCN N/A
- Industry
- EFOI Building Products
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- EFOI Consumer Discretionary
- LPCN Health Care
- Exchange
- EFOI Nasdaq
- LPCN Nasdaq
- Market Cap
- EFOI 14.9M
- LPCN 13.8M
- IPO Year
- EFOI 1994
- LPCN N/A
- Fundamental
- Price
- EFOI $2.35
- LPCN $3.18
- Analyst Decision
- EFOI
- LPCN Strong Buy
- Analyst Count
- EFOI 0
- LPCN 1
- Target Price
- EFOI N/A
- LPCN $7.00
- AVG Volume (30 Days)
- EFOI 6.3K
- LPCN 54.7K
- Earning Date
- EFOI 11-12-2025
- LPCN 11-06-2025
- Dividend Yield
- EFOI N/A
- LPCN N/A
- EPS Growth
- EFOI N/A
- LPCN N/A
- EPS
- EFOI N/A
- LPCN N/A
- Revenue
- EFOI $3,863,000.00
- LPCN $4,322,693.00
- Revenue This Year
- EFOI N/A
- LPCN N/A
- Revenue Next Year
- EFOI N/A
- LPCN N/A
- P/E Ratio
- EFOI N/A
- LPCN N/A
- Revenue Growth
- EFOI N/A
- LPCN N/A
- 52 Week Low
- EFOI $1.19
- LPCN $2.52
- 52 Week High
- EFOI $3.56
- LPCN $5.50
- Technical
- Relative Strength Index (RSI)
- EFOI 40.42
- LPCN 61.21
- Support Level
- EFOI $2.26
- LPCN $3.07
- Resistance Level
- EFOI $2.40
- LPCN $3.32
- Average True Range (ATR)
- EFOI 0.13
- LPCN 0.20
- MACD
- EFOI -0.01
- LPCN 0.06
- Stochastic Oscillator
- EFOI 25.53
- LPCN 65.82
About EFOI Energy Focus Inc.
Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.